Highlights and Quick Summary
- Debt/Assets for the quarter ending June 30, 2023 was 11.55% (a 12.03% increase compared to previous quarter)
- Year-over-year quarterly Debt/Assets increased by 10.95%
- Annual Debt/Assets for 2022 was 9.95% (a 29.73% increase from previous year)
- Annual Debt/Assets for 2021 was 7.67% (a Infinity% increase from previous year)
- Annual Debt/Assets for 2020 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Debt/Assets of Dyne Therapeutics, Inc.
Most recent Debt/Assetsof DYN including historical data for past 10 years.Interactive Chart of Debt/Assets of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Debt/Assets for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 11.55% | 10.31% | – | – | – |
| 2022 | 9.95% | 10.41% | 9.66% | 8.45% | 9.95% |
| 2021 | 7.67% | 7.28% | 0.09% | 0.12% | 7.67% |
| 2020 | 0.0% | 2.6% | 0.0% | 0.0% | 0.0% |
| 2019 | – | – | 0.0% | 0.0% | 0.0% |
| 2018 | – | – | – | – | 40.82% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology